You are here: Industry Insights > COVID-19

News List

EMA issues advice on use of Lagevrio for the treatment of COVID-19 EuropeanPharmaceuticalReview
November 25, 2021
The European Medicines Agency (EMA)’s human medicine committee, the Committee for Medicinal Products for Human Use (CHMP), has issued advice on the use of Lagevrio...
Oncotelic’s OT-101 meets safety and efficacy goals in Covid-19 trial Pharmaceutical-Technology
November 25, 2021
Oncotelic Therapeutics has reported that its lead drug candidate, OT-101, met the safety and efficacy goals of Phase II C001 clinical trial in individuals with severe Covid-19 who are admitted to the hospital.
Singapore Brand Buzud Launches Patented Oxygen Concentrator prnasia
November 24, 2021
Buzud, a Singapore brand of medical and beauty devices, has launched the Buzud Oxygen Concentrator and unveiled its first retail store located on level 1 of Raffles Hospital.
Chinese mainland reports 7 locally transmitted COVID-19 cases NMPA
November 24, 2021
The Chinese mainland on Nov 21 reported seven new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Nov 22.
Testing Before Turkey, Covid Holiday Planning prnewswire
November 24, 2021
As Americans make their final plans to gather for Thanksgiving, Sterling Pathology is urging people to plan on rapid and PCR tests to prevent holiday spread of Covid-19.
Todos Medical concludes enrolment in Phase II oral drug trial for Covid-19 Pharmaceutical-Technology
November 24, 2021
Todos Medical, along with its partner, NLC Pharma, has concluded subject enrolment to carry out an interim assessment of the Phase II clinical trial of oral antiviral drug, Tollovir, in severe and critical Covid-19 patients who are in hospital.
Pulmonem initiates US subject recruitment in Phase III Covid-19 drug trial Pharmaceutical-Technology
November 24, 2021
Pulmonem and the Research Institute of the McGill University Health Centre have commenced US-based subject enrolment in the Phase III clinical trial of the drug, PULM-001, for Covid-19.
EMA supports molnupiravir prior to formal authorisation PharmaTimes
November 23, 2021
The European Medicines Agency (EMA) has issued emergency use advice (EUA) supporting a decision by national authorities for the possible early use of Merck's molnupiravir, the oral antiviral drug for the treatment of patients with COVID-19.
UK recognises Covaxin as valid COVID-19 vaccine for travel PharmaTimes
November 23, 2021
Travellers vaccinated with Bharat Biotech’s Covaxin will now be able to enter the UK, as the vaccine has been added to the approved list. This means that those inoculated with Covaxin...
Simcere and Shanghai Institute of Materia Medica Enter a Collaboration to Jointly Develop Next-Gen COVID-19 Oral Antiviral Treatments prnasia
November 23, 2021
On November 17, 2021, Simcere Pharmaceutical Group Limited (2096.HK) announced that the company has reached collaboration agreement with the Shanghai Institute of Materia Medica (SIMM)...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page